Your session is about to expire
← Back to Search
Lumacaftor Film-Coated Tablets for Healthy Subjects
Study Summary
This trial tests if a generic version of a drug combo is as effective as the original, and if food affects its bioavailability.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 458 Patients • NCT04043806Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has Treatment A (Test-Fed) been acknowledged by the FDA as safe for use?
"Our team at Power has assessed that Treatment A (Test-Fed) presents a low safety risk, as it is currently in its first clinical trial phase and only preliminary data exists to support both efficacy and security."
Are there any current opportunities to enroll in this research endeavor?
"As per the information presented on clinicaltrials.gov, this study has been actively recruiting participants since October 1st, 2023 and was recently updated as of October 5th, 2023."
Does this experiment permit elderly participants?
"This clinical trial only permits those aged between 18 and 55 to join. Meanwhile, there are 65 research studies catered for minors under 18 years old, while 398 trials focus on seniors who exceed the age of 65."
How many participants are included in the ongoing clinical trial?
"Affirmative. According to information posted on clinicaltrials.gov, this medical experiment is actively enlisting participants since October 1st 2023. As of now, 39 patients need to be gathered from a single location and the trial has been updated recently on October 5th 2023."
Can I sign up for this medical research program?
"This clinical trial is recruiting 39 participants aged 18 to 55 who are considered healthy. Eligible applicants must not smoke, have a BMI between 18.5 and 30.0 kg/m2, have normal lab results according to the principal investigator's discretion, be able to fast for 10 hours and consume high-fat meals as well as regular food items, agree not to get tattoos or piercings during participation in the study, abstain from receiving Covid-19 vaccinations within 7 days of their first dose until seven days after their last dose administration and if they are either of reproductive age or capable of fathering children meet certain criteria outlined"
Share this study with friends
Copy Link
Messenger